Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. G. Gorenkova
Potentials of Brentuximab Vedotin in the Treatment of Relapse/Refractory Cutaneous T-Cell Lymphomas: Literature Review and Authors’ Observation
Vestnik dermatologii i venerologii
Related publications
Successful Outcomes of Brentuximab Vedotin Therapy in Recurrent/Refractory Cutaneous T-Cell Lymphomas: Two Case Reports
Immunopathology, Allergology, Infectology
Brentuximab Vedotin: New Possibilities for Treatment of Relapses and Refractory Hodgkin’s Lymphomas
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Our First Experiences With Brentuximab Vedotin in the Treatment of Cutaneous T-Cell Lymphoma
Bőrgyógyászati és Venerológiai Szemle
Brentuximab Vedotin for Treatment of Non-Hodgkin Lymphomas: A Systematic Review
Critical Reviews in Oncology/Hematology
Gerontology
Geriatrics
Hematology
Oncology
A Phase Ii Trial of Brentuximab Vedotin (Bv) and Lenalidomide (Len) in Relapsed and Refractory (R/R) Cutaneous (Ctcl) and Peripheral (Ptcl) T-Cell Lymphomas: Preliminary Results of a Phase Ii Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
FDA Approval Summary: Brentuximab Vedotin in First‐Line Treatment of Peripheral T‐Cell Lymphoma
Oncologist
Cancer Research
Medicine
Oncology
Profile of Brentuximab Vedotin and Its Potential in the Treatment of Relapsed or Refractory Hodgkin Lymphoma
Blood and Lymphatic Cancer: Targets and Therapy
Primary Cutaneous Acral CD8+ T-Cell Lymphomas Relapse More Frequently in Younger Patients
British Journal of Haematology
Hematology
Pegylated Liposomal Doxorubicin in the Treatment of Primary Cutaneous T-Cell Lymphomas
Haematologica
Hematology
